secwatch.observer — SEC 8-K summary
======================================

Issuer:     BrightSpring Health Services, Inc. (BTSG)
CIK:        0001865782
Form:       8-K
Filed at:   2024-08-02T23:59:59+00:00
Accession:  0000950170-24-089576
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BrightSpring Q2 revenue up 26% to $2.73B, raises FY2024 guidance
----------------------------------------------------------------

- Revenue $2.73B (+26% YoY); net income $19.4M vs $2.8M in Q2 2023.
- Adj. EBITDA $139M (-6.9% YoY) but excluding $30M 2023 QIP, up 16.7%.
- Pharmacy Solutions revenue $2.11B (+32%); Provider Services $616M (+8%).
- FY2024 guidance raised: revenue $10.45-10.9B, Adj. EBITDA $570-580M.
- CEO cites strong segment growth and operational execution.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1865782/000095017024089576/0000950170-24-089576-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1865782/000095017024089576/btsg-20240802.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-089576

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer